Parvovirus B19-induced anemia as the presenting manifestation of X- linked hyper-IgM syndrome

Journal of Infectious Diseases

Volumn 178, Issue 2, 1998, Pages 318-324

  Seyama, Kuniaki ^b   Kobayashi, Roger ^b   Hasle, Henrik ^b   Apter, Andrea J ^b   Rutledge, Joe C ^b   Rosen, David ^b   Ochs, Hans D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M;

ANEMIA; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CHROMOSOME LOSS; HUMAN; HUMAN CELL; HYPERIMMUNOGLOBULINEMIA; IMMUNE DEFICIENCY; MISSENSE MUTATION; PARVOVIRUS; PRIORITY JOURNAL; START CODON; VIRUS INFECTION; X CHROMOSOME LINKAGE;

EID: 0031821822     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515633     Document Type: Article

References (20)

1. Brown KE, Young NS, Liu JM. Molecular, cellular and clinical aspects of parvovirus B19. Crit Rev Oncol Hematol 1994;16:1-31.
2. Kerr JR. Parvovirus B19 infection. Eur J Clin Microbiol Infect Dis 1996; 15:10-29.
3. Anderson MJ, Jones SE, Fisher-Hoch SP, et al. Human parvovirus, the cause of erythema infectiosum (fifth disease)? [letter]. Lancet 1983;1: 1378.
4. White DG, Woolf AD, Mortimer PP, Cohen BJ, Blake DR, Bacon PA. Human parvovirus arthropathy. Lancet 1985;1:419-21.
5. Reid DM, Reid TM, Brown T, Rennie JAN, Eastmond CJ. Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet 1985;1:422-5.
6. Kurtzman GJ, Ozawa K, Cohen B, Hanson G, Oseas R, Young NS. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 1987;317:287-94.
7. Kurtzman GJ, Cohen B, Meyers P, Amunullah A, Young NS. Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet 1988;2:1159-62.
8. Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 1989;321:519-23.
9. Gahr M, Pekrun A, Eiffert H. Persistence of parvovirus B19-DNA in blood of a child with severe combined immunodeficiency associated with chronic pure red cell aplasia. Eur J Pediatr 1991;150:470-2.
10. Hasle H, Kerndrup G, Jacobsen BB, Heegaard ED, Homsleth A, Lillevang ST. Chronic parvovirus infection mimicking myelodysplastic syndrome in a child with subclinical immunodeficiency. Am J Pediatr Hematol Oncol 1994;16:329-33.
11. Tang MLK, Kemp AS, Moaven LD. Parvovirus B19-associated red blood cell aplasia in combined immunodeficiency with normal immunoglobulins. Pediatr Infect Dis J 1994;13:539-42.
12. Frickhofen N, Abkowitz JL, Safford M, et al. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med 1990; 113:926-33.
13. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993;262:114-7.
14. Anderson MJ, Higgins PG, Davis LR, et al. Experimental parvoviral infection in humans. J Infect Dis 1985;152:257-65.
15. Pattison JR, Jones SE, Hodgson J, et al. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet 1981;1:664-5.
16. Kelleher JF, Luban NLC, Mortimer PP, Kamimura T. Human serum "parvovirus": a specific cause of aplastic crisis in children with hereditary spherocytosis. J Pediatr 1983;102:720-2.
17. Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blaese RM, Young NS. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 1989;84:1114-23.
18. Levy J, Espanol-Boren T, Thomas C, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997;131:47-54.
19. Aruffo A, Farrington M, Hollenbaugh D, et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 1993;72:291-300.
20. Allen RC, Armitage RJ, Conley ME, et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993;259:990-3.